Literature DB >> 25941337

Tumor twitter: cellular communication in the breast cancer stem cell niche.

Michael D Brooks1, Max S Wicha2.   

Abstract

Communication between the diverse assortment of cells that constitute the tumor microenvironment plays an important role in tumor development. Using a p53-null mouse model, Zhang and colleagues describe a novel feedback loop involving breast cancer stem cells and their progeny mediated by WNT2, CXCL12, and IL6. ©2015 American Association for Cancer Research.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25941337      PMCID： PMC4422104          DOI： 10.1158/2159-8290.CD-15-0327

Source DB:  PubMed          Journal:  Cancer Discov        ISSN： 2159-8274            Impact factor:   39.397


  10 in total

1.  Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling.

Authors:  Christine M Fillmore; Piyush B Gupta; Jenny A Rudnick; Silvia Caballero; Patricia J Keller; Eric S Lander; Charlotte Kuperwasser
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

Review 2.  The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?

Authors:  Vicki Plaks; Niwen Kong; Zena Werb
Journal:  Cell Stem Cell       Date:  2015-03-05       Impact factor: 24.633

Review 3.  Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance.

Authors:  Hariharan Easwaran; Hsing-Chen Tsai; Stephen B Baylin
Journal:  Mol Cell       Date:  2014-06-05       Impact factor: 17.970

4.  Intratumoral heterogeneity in a Trp53-null mouse model of human breast cancer.

Authors:  Mei Zhang; Anna Tsimelzon; Chi-Hsuan Chang; Cheng Fan; Andrew Wolff; Charles M Perou; Susan G Hilsenbeck; Jeffrey M Rosen
Journal:  Cancer Discov       Date:  2015-03-03       Impact factor: 39.397

5.  Progesterone and Wnt4 control mammary stem cells via myoepithelial crosstalk.

Authors:  Renuga Devi Rajaram; Duje Buric; Marian Caikovski; Ayyakkannu Ayyanan; Jacques Rougemont; Jingdong Shan; Seppo J Vainio; Ozden Yalcin-Ozuysal; Cathrin Brisken
Journal:  EMBO J       Date:  2015-01-20       Impact factor: 11.598

6.  Identification of tumor-initiating cells in a p53-null mouse model of breast cancer.

Authors:  Mei Zhang; Fariba Behbod; Rachel L Atkinson; Melissa D Landis; Frances Kittrell; David Edwards; Daniel Medina; Anna Tsimelzon; Susan Hilsenbeck; Jeffrey E Green; Aleksandra M Michalowska; Jeffrey M Rosen
Journal:  Cancer Res       Date:  2008-06-15       Impact factor: 12.701

Review 7.  The microenvironment in breast cancer progression: biology and implications for treatment.

Authors:  Andrew E Place; Sung Jin Huh; Kornelia Polyak
Journal:  Breast Cancer Res       Date:  2011-11-01       Impact factor: 6.466

8.  Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer.

Authors:  Aleix Prat; Joel S Parker; Olga Karginova; Cheng Fan; Chad Livasy; Jason I Herschkowitz; Xiaping He; Charles M Perou
Journal:  Breast Cancer Res       Date:  2010-09-02       Impact factor: 6.466

9.  Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts.

Authors:  Suling Liu; Yang Cong; Dong Wang; Yu Sun; Lu Deng; Yajing Liu; Rachel Martin-Trevino; Li Shang; Sean P McDermott; Melissa D Landis; Suhyung Hong; April Adams; Rosemarie D'Angelo; Christophe Ginestier; Emmanuelle Charafe-Jauffret; Shawn G Clouthier; Daniel Birnbaum; Stephen T Wong; Ming Zhan; Jenny C Chang; Max S Wicha
Journal:  Stem Cell Reports       Date:  2013-12-27       Impact factor: 7.765

10.  Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity.

Authors:  Andriy Marusyk; Doris P Tabassum; Philipp M Altrock; Vanessa Almendro; Franziska Michor; Kornelia Polyak
Journal:  Nature       Date:  2014-07-30       Impact factor: 49.962
  10 in total
  16 in total

1.  Developmental Insights into Breast Cancer Intratumoral Heterogeneity.

Authors:  Mei Zhang; Jeffrey M Rosen
Journal:  Trends Cancer       Date:  2015-12-01

2.  Epithelial Stem Cells: Making, Shaping and Breaking the Niche.

Authors:  Paula Ferraces-Riegas; Anona C Galbraith; David P Doupé
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

3.  Properties and feasibility of using cancer stem cells in clinical cancer treatment.

Authors:  Xiao-Mei Gao; Rui Zhang; Qiong-Zhu Dong; Lun-Xiu Qin
Journal:  Cancer Biol Med       Date:  2016-12       Impact factor: 4.248

4.  MiR-129 blocks estrogen induction of NOTCH signaling activity in breast cancer stem-like cells.

Authors:  Guodong Xiao; Xiang Li; Gang Li; Boxiang Zhang; Chongwen Xu; Sida Qin; Ning Du; Jichang Wang; Shou-Ching Tang; Jing Zhang; Hong Ren; Ke Chen; Xin Sun
Journal:  Oncotarget       Date:  2017-09-21

5.  TRIM28 multi-domain protein regulates cancer stem cell population in breast tumor development.

Authors:  Patrycja Czerwińska; Parantu K Shah; Katarzyna Tomczak; Marta Klimczak; Sylwia Mazurek; Barbara Sozańska; Przemysław Biecek; Konstanty Korski; Violetta Filas; Andrzej Mackiewicz; Jannik N Andersen; Maciej Wiznerowicz
Journal:  Oncotarget       Date:  2017-01-03

6.  BCMA (TNFRSF17) Induces APRIL and BAFF Mediated Breast Cancer Cell Stemness.

Authors:  Vasiliki Pelekanou; George Notas; Paraskevi Athanasouli; Konstantinos Alexakis; Fotini Kiagiadaki; Nikolaos Peroulis; Konstantina Kalyvianaki; Errika Kampouri; Hara Polioudaki; Panayiotis Theodoropoulos; Andreas Tsapis; Elias Castanas; Marilena Kampa
Journal:  Front Oncol       Date:  2018-08-07       Impact factor: 6.244

Review 7.  Cytokines, breast cancer stem cells (BCSCs) and chemoresistance.

Authors:  Weilong Chen; Yuanyuan Qin; Suling Liu
Journal:  Clin Transl Med       Date:  2018-09-03

Review 8.  New Findings on Breast Cancer Stem Cells: A Review.

Authors:  Azam Bozorgi; Mozafar Khazaei; Mohammad Rasool Khazaei
Journal:  J Breast Cancer       Date:  2015-12-23       Impact factor: 3.588

Review 9.  Nanomedicine-Mediated Therapies to Target Breast Cancer Stem Cells.

Authors:  Lili He; Jian Gu; Lee Y Lim; Zhi-Xiang Yuan; Jingxin Mo
Journal:  Front Pharmacol       Date:  2016-09-13       Impact factor: 5.810

10.  Metabolomic mapping of cancer stem cells for reducing and exploiting tumor heterogeneity.

Authors:  Elisabet Cuyàs; Sara Verdura; Salvador Fernández-Arroyo; Joaquim Bosch-Barrera; Begoña Martin-Castillo; Jorge Joven; Javier A Menendez
Journal:  Oncotarget       Date:  2017-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.